Some research has suggested that patients with CFRD exhibit lower levels of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) than those without diabetes and control groups [9], which may contribute to the postprandial hyperglycaemic excursions often seen in early CFRD [6]. This evidence concerns the gene GCG and diabetes mellitus.